Page last updated: 2024-10-24

glucose mediated signaling pathway

Definition

Target type: biologicalprocess

The process in which a change in the level of mono- and disaccharide glucose trigger the expression of genes controlling metabolic and developmental processes. [GOC:sm]

Glucose-mediated signaling pathways are intricate networks that regulate cellular responses to glucose availability. These pathways play a pivotal role in maintaining glucose homeostasis, regulating metabolism, and influencing cell growth, differentiation, and survival. The core of glucose signaling involves a series of interconnected events triggered by the binding of glucose to specific receptors on the cell surface.

**1. Glucose Uptake and Transport:** Glucose enters cells through facilitated diffusion facilitated by glucose transporters (GLUTs). The expression and activity of GLUTs are tightly regulated, ensuring the appropriate uptake of glucose based on cellular demands.

**2. Glucose Metabolism and ATP Generation:** Once inside the cell, glucose is metabolized through glycolysis, a series of enzymatic reactions that convert glucose into pyruvate. This process generates ATP, the primary energy currency of the cell.

**3. Sensing Glucose Levels:** The intracellular concentration of glucose is sensed by various mechanisms, including:
* **Hexokinase:** This enzyme catalyzes the first step of glycolysis, phosphorylation of glucose to glucose-6-phosphate. Hexokinase activity is influenced by glucose levels, providing an initial feedback loop.
* **AMPK:** AMP-activated protein kinase (AMPK) is activated by low energy levels (increased AMP/ATP ratio) and acts as a sensor of cellular energy status. AMPK activation can suppress glucose uptake and stimulate glucose production.
* **mTOR:** The mammalian target of rapamycin (mTOR) pathway integrates nutrient availability and growth factor signaling. It is activated by glucose and amino acid levels, promoting cell growth and protein synthesis.

**4. Insulin Signaling Pathway:** Insulin, a hormone secreted by the pancreas in response to elevated blood glucose levels, plays a central role in glucose signaling. Insulin binds to its receptor (INSR) on the cell surface, triggering a cascade of intracellular signaling events:
* **Tyrosine Kinase Activity:** Insulin binding activates the intrinsic tyrosine kinase activity of the INSR, leading to autophosphorylation of the receptor and phosphorylation of downstream signaling molecules.
* **PI3K/Akt Pathway:** The activated INSR recruits and activates phosphatidylinositol 3-kinase (PI3K), which phosphorylates phosphatidylinositol (PIP2) to generate PIP3. PIP3 activates protein kinase B (Akt), a key player in insulin signaling.
* **GLUT4 Translocation:** Akt promotes the translocation of GLUT4 transporters from intracellular vesicles to the cell membrane, facilitating glucose uptake.
* **Glycogen Synthesis:** Akt also activates glycogen synthase, promoting the synthesis of glycogen, a storage form of glucose.
* **Other Targets:** Akt regulates a multitude of downstream targets, including protein synthesis, cell growth, and survival.

**5. Other Glucose-Responsive Pathways:** Several other signaling pathways are influenced by glucose levels, including:
* **AMPK:** AMPK activation by low glucose levels leads to the inhibition of glucose uptake and the activation of fatty acid oxidation, providing an alternative energy source.
* **HIF1α:** Hypoxia-inducible factor 1α (HIF1α) is stabilized under low oxygen conditions, but glucose availability also influences its activity. HIF1α promotes the expression of genes involved in glucose uptake and glycolysis.
* **PPARs:** Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors involved in lipid metabolism. PPARα is activated by fatty acids, but glucose can also influence its activity.

**6. Glucose Signaling Dysregulation:** Disruptions in glucose-mediated signaling pathways can contribute to various metabolic disorders, including:
* **Type 2 Diabetes:** Insulin resistance, a condition where cells do not respond appropriately to insulin, is a hallmark of type 2 diabetes. Insulin resistance can result from defects in the insulin signaling pathway, leading to impaired glucose uptake and elevated blood glucose levels.
* **Obesity:** Dysregulation of glucose signaling pathways can contribute to the development of obesity by promoting energy storage and reducing energy expenditure.
* **Cancer:** Cancer cells often exhibit altered glucose metabolism, exhibiting increased glucose uptake and glycolysis. This metabolic shift provides the necessary energy and building blocks for tumor growth.

In summary, glucose-mediated signaling pathways are essential for maintaining cellular homeostasis and regulating a wide range of physiological processes. These pathways are complex, highly integrated, and subject to intricate regulation, highlighting the critical role of glucose as a key signaling molecule.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Advanced glycosylation end product-specific receptorAn advanced glycosylation end product-specific receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15109]Homo sapiens (human)
Adenylate cyclase type 8An adenylate cyclase type 8 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P40145]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
quinolinic acidpyridinedicarboxylic acid : Any member of the class of pyridines carrying two carboxy groups.

quinolinic acid : A pyridinedicarboxylic acid that is pyridine substituted by carboxy groups at positions 2 and 3. It is a metabolite of tryptophan.

Quinolinic Acid: A metabolite of tryptophan with a possible role in neurodegenerative disorders. Elevated CSF levels of quinolinic acid are correlated with the severity of neuropsychological deficits in patients who have AIDS.
pyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
colforsinColforsin: Potent activator of the adenylate cyclase system and the biosynthesis of cyclic AMP. From the plant COLEUS FORSKOHLII. Has antihypertensive, positive inotropic, platelet aggregation inhibitory, and smooth muscle relaxant activities; also lowers intraocular pressure and promotes release of hormones from the pituitary gland.acetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol
adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
matrinealkaloid
sch 23390SCH 23390 : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1, a methyl substituent at position 3, a chloro substituent at position 7 and a hydroxy substituent at position 8.

SCH 23390: a selective D1-receptor antagonist
benzazepine
sk&f-38393(R)-SKF 38393 : A 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol that is the R-enantiomer of SKF 38393.1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
vilazodonevilazodone : A 1-benzofuran that is 5-(piperazin-1-yl}-1-benzofuran-2-carboxamide having a (5-cyanoindol-3-yl)butyl group attached at position N-4 on the piperazine ring. Used for the treatment of major depressive disorder.1-benzofurans;
indoles;
monocarboxylic acid amide;
N-alkylpiperazine;
N-arylpiperazine;
nitrile
antidepressant;
serotonergic agonist;
serotonin uptake inhibitor
fps-zm1FPS-ZM1: a neuroprotective agent and RAGE receptor antagonist; structure in first source
n(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithineN(delta)-(5-methyl-4-oxo-2-imidazolin-2-yl)ornithine: RN given for (L)-isomer; structure in first source